Sword Health valuation, funding and investors
Sword Health works in AI-Driven healthcare solutions development, based in New York, United States. Founded in 2015, it has about 1,130 employees.
- Last round
- Growth · $40.0M · Jun 2025
- Valuation at last round
- $3.93B
- Headcount
- 1,180 · up
- Grade
- A
- Founded
- 2015
Sword Health valuation today
VCMC values Sword Health at $4.2B today, with a range of $3.0B to $5.0B and a grade of A. The valuation starts from its last funding round, a growth round in Jun 2025.
Valuation by date (150 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2015 | $5.25M | $1.91M – $14.4M | $5.51M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2015 | $5.28M | $1.92M – $14.5M | $5.53M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2015 | $5.29M | $1.93M – $14.5M | $5.55M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2015 | $5.32M | $1.93M – $14.6M | $5.57M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2015 | $5.34M | $1.94M – $14.7M | $5.59M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2015 | $5.36M | $1.95M – $14.7M | $5.61M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2015 | $5.38M | $1.96M – $14.8M | $5.64M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2015 | $5.40M | $1.97M – $14.8M | $5.78M (+7%) | before first round | – | unknown | D | 0% |
| 1 Sep 2015 | $5.42M | $1.97M – $14.9M | $5.94M (+10%) | before first round | – | unknown | D | 0% |
| 1 Oct 2015 | $5.44M | $1.98M – $14.9M | $6.09M (+12%) | before first round | – | unknown | D | 0% |
| 1 Nov 2015 | $5.46M | $1.99M – $15.0M | $6.26M (+15%) | before first round | – | unknown | D | 0% |
| 1 Dec 2015 | $5.48M | $2.00M – $15.1M | $6.42M (+17%) | before first round | – | unknown | D | 0% |
| 1 Jan 2016 | $5.51M | $2.00M – $15.1M | $6.60M (+20%) | before first round | – | unknown | D | 0% |
| 1 Feb 2016 | $5.53M | $2.01M – $15.2M | $6.78M (+23%) | before first round | – | unknown | D | 0% |
| 1 Mar 2016 | $5.55M | $2.02M – $15.2M | $6.95M (+25%) | before first round | – | unknown | D | 0% |
| 1 Apr 2016 | $5.57M | $2.03M – $15.3M | $7.14M (+28%) | before first round | – | unknown | D | 0% |
| 1 May 2016 | $5.59M | $2.04M – $15.4M | $7.33M (+31%) | before first round | – | unknown | D | 0% |
| 1 Jun 2016 | $5.61M | $2.04M – $15.4M | $7.53M (+34%) | before first round | – | unknown | D | 0% |
| 1 Jul 2016 | $5.64M | $2.05M – $15.5M | $7.72M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2016 | $5.79M | $2.11M – $15.9M | $7.93M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2016 | $5.94M | $2.16M – $16.3M | $8.15M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2016 | $6.10M | $2.22M – $16.8M | $8.36M (+37%) | before first round | – | unknown | D | 0% |
| 1 Nov 2016 | $6.26M | $2.28M – $17.2M | $8.59M (+37%) | before first round | – | unknown | D | 0% |
| 1 Dec 2016 | $6.43M | $2.34M – $17.7M | $8.81M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jan 2017 | $6.60M | $2.40M – $18.1M | $9.05M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2017 | $6.78M | $2.47M – $18.6M | $9.29M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2017 | $6.94M | $2.53M – $19.1M | $9.52M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2017 | $7.13M | $2.60M – $19.6M | $9.78M (+37%) | before first round | – | unknown | D | 0% |
| 1 May 2017 | $7.32M | $2.67M – $20.1M | $10.0M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jun 2017 | $7.52M | $2.74M – $20.7M | $10.3M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jul 2017 | $7.72M | $2.81M – $21.2M | $10.6M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2017 | $7.93M | $2.89M – $21.8M | $10.9M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2017 | $8.14M | $2.96M – $22.4M | $11.2M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2017 | $8.36M | $3.04M – $23.0M | $11.5M (+37%) | before first round | – | unknown | D | 0% |
| 1 Nov 2017 | $8.58M | $3.12M – $23.6M | $11.8M (+37%) | before first round | – | unknown | D | 0% |
| 1 Dec 2017 | $8.81M | $3.21M – $24.2M | $12.1M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jan 2018 | $9.05M | $3.29M – $24.9M | $12.4M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2018 | $9.29M | $3.38M – $25.5M | $12.7M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2018 | $9.52M | $3.47M – $26.2M | $13.1M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2018 | $9.78M | $3.56M – $26.9M | $13.4M (+37%) | before first round | – | unknown | D | 0% |
| 17 Apr 2018 | $30.7M | $20.1M – $93.3M | $61.3M (+100%) | after a round | – | unknown | C | 0% |
| 1 May 2018 | $31.6M | $20.1M – $93.3M | $61.3M (+94%) | after a round | – | unknown | C | 0% |
| 1 Jun 2018 | $33.5M | $20.1M – $93.3M | $61.3M (+83%) | after a round | – | unknown | C | 0% |
| 1 Jul 2018 | $35.4M | $20.1M – $93.3M | $61.3M (+73%) | after a round | – | unknown | C | 0% |
| 1 Aug 2018 | $37.6M | $20.1M – $93.3M | $61.3M (+63%) | after a round | – | unknown | C | 0% |
| 1 Sep 2018 | $39.8M | $20.1M – $93.3M | $61.3M (+54%) | after a round | – | unknown | C | 0% |
| 1 Oct 2018 | $42.2M | $20.1M – $93.3M | $61.3M (+45%) | after a round | – | unknown | C | 0% |
| 1 Nov 2018 | $44.7M | $20.1M – $93.3M | $61.3M (+37%) | after a round | – | unknown | C | 0% |
| 1 Dec 2018 | $47.4M | $20.1M – $93.3M | $61.3M (+30%) | after a round | – | unknown | C | 0% |
| 1 Jan 2019 | $50.2M | $20.1M – $93.3M | $61.3M (+22%) | after a round | – | unknown | C | 0% |
| 1 Feb 2019 | $53.3M | $20.1M – $93.3M | $61.3M (+15%) | after a round | – | unknown | C | 0% |
| 1 Mar 2019 | $56.2M | $20.1M – $93.3M | $61.3M (+9%) | after a round | – | unknown | C | 0% |
| 1 Apr 2019 | $59.6M | $20.1M – $93.3M | $61.3M (+3%) | after a round | – | unknown | C | 0% |
| 17 Apr 2019 | $49.6M | $34.9M – $126M | $89.1M (+80%) | after a round | – | unknown | C | 0% |
| 1 May 2019 | $50.7M | $34.9M – $126M | $89.1M (+76%) | after a round | – | unknown | C | 0% |
| 1 Jun 2019 | $53.3M | $34.9M – $126M | $89.1M (+67%) | after a round | – | unknown | C | 0% |
| 1 Jul 2019 | $55.9M | $34.9M – $126M | $89.1M (+59%) | after a round | – | unknown | C | 0% |
| 1 Aug 2019 | $58.8M | $34.9M – $126M | $89.1M (+52%) | after a round | – | unknown | C | 0% |
| 1 Sep 2019 | $61.8M | $34.9M – $126M | $89.1M (+44%) | after a round | – | unknown | C | 0% |
| 1 Oct 2019 | $64.8M | $34.9M – $126M | $89.1M (+37%) | after a round | – | unknown | C | 0% |
| 1 Nov 2019 | $68.2M | $34.9M – $126M | $89.1M (+31%) | after a round | – | unknown | C | 0% |
| 1 Dec 2019 | $71.5M | $34.9M – $126M | $89.1M (+25%) | after a round | – | unknown | C | 0% |
| 1 Jan 2020 | $75.2M | $34.9M – $126M | $89.1M (+18%) | after a round | – | unknown | C | 0% |
| 1 Feb 2020 | $79.0M | $34.9M – $126M | $89.1M (+13%) | after a round | – | unknown | C | 0% |
| 1 Mar 2020 | $82.8M | $34.9M – $126M | $89.1M (+8%) | after a round | – | unknown | C | 0% |
| 1 Apr 2020 | $87.1M | $34.9M – $126M | $89.1M (+2%) | after a round | – | unknown | C | 0% |
| 1 May 2020 | $89.1M | $34.0M – $126M | $89.1M (0%) | after a round | – | unknown | C | 0% |
| 1 Jun 2020 | $89.1M | $32.3M – $126M | $89.1M (0%) | after a round | – | unknown | C | 0% |
| 1 Jul 2020 | $89.1M | $30.7M – $126M | $89.1M (0%) | after a round | – | unknown | C | 0% |
| 1 Aug 2020 | $89.1M | $29.2M – $126M | $89.1M (0%) | after a round | – | unknown | C | 0% |
| 1 Sep 2020 | $89.1M | $27.8M – $126M | $89.1M (0%) | after a round | – | unknown | C | 0% |
| 1 Oct 2020 | $89.1M | $26.4M – $126M | $89.1M (0%) | after a round | – | unknown | C | 0% |
| 1 Nov 2020 | $89.1M | $25.1M – $126M | $89.1M (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2020 | $89.1M | $23.9M – $126M | $89.1M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2021 | $89.1M | $22.7M – $126M | $89.1M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2021 | $155M | $109M – $331M | $233M (+50%) | after a round | – | unknown | B | 0% |
| 2 Feb 2021 | $156M | $109M – $331M | $233M (+50%) | after a round | – | unknown | B | 0% |
| 1 Mar 2021 | $160M | $109M – $331M | $233M (+45%) | after a round | – | unknown | B | 0% |
| 1 Apr 2021 | $166M | $109M – $331M | $233M (+40%) | after a round | – | unknown | B | 0% |
| 1 May 2021 | $171M | $109M – $331M | $233M (+36%) | after a round | – | unknown | B | 0% |
| 1 Jun 2021 | $177M | $109M – $331M | $233M (+31%) | after a round | – | unknown | B | 0% |
| 1 Jul 2021 | $184M | $109M – $331M | $233M (+27%) | after a round | – | unknown | B | 0% |
| 7 Jul 2021 | $500M | $435M – $748M | $650M (+30%) | after a round | – | unknown | A | 0% |
| 1 Aug 2021 | $509M | $435M – $748M | $650M (+28%) | after a round | – | unknown | A | 0% |
| 1 Sep 2021 | $521M | $435M – $748M | $650M (+25%) | after a round | – | unknown | A | 0% |
| 1 Oct 2021 | $532M | $435M – $748M | $650M (+22%) | after a round | – | unknown | A | 0% |
| 1 Nov 2021 | $544M | $435M – $748M | $650M (+19%) | after a round | – | unknown | A | 0% |
| 23 Nov 2021 | $2.0B | $1.7B – $3.0B | $2.6B (+30%) | after a round | – | unknown | A | 0% |
| 1 Dec 2021 | $2.0B | $1.7B – $3.0B | $2.6B (+29%) | after a round | – | unknown | A | 0% |
| 1 Jan 2022 | $2.1B | $1.7B – $3.0B | $2.6B (+26%) | after a round | – | unknown | A | 0% |
| 1 Feb 2022 | $2.1B | $1.7B – $3.0B | $2.6B (+24%) | after a round | – | unknown | A | 0% |
| 1 Mar 2022 | $2.1B | $1.7B – $3.0B | $2.6B (+21%) | after a round | 370 | unknown | A | 0% |
| 1 Apr 2022 | $2.2B | $1.7B – $3.0B | $2.6B (+18%) | after a round | 370 | unknown | A | 0% |
| 1 May 2022 | $2.2B | $1.7B – $3.0B | $2.6B (+16%) | after a round | 370 | unknown | A | 0% |
| 1 Jun 2022 | $2.3B | $1.7B – $3.0B | $2.6B (+13%) | after a round | 370 | unknown | A | 0% |
| 1 Jul 2022 | $2.3B | $1.7B – $3.0B | $2.6B (+11%) | after a round | 370 | unknown | A | 0% |
| 1 Aug 2022 | $2.4B | $1.7B – $3.0B | $2.6B (+8%) | after a round | 370 | unknown | A | 0% |
| 1 Sep 2022 | $2.5B | $1.7B – $3.0B | $2.6B (+6%) | after a round | 370 | unknown | A | 0% |
| 1 Oct 2022 | $2.5B | $1.7B – $3.0B | $2.6B (+4%) | after a round | 370 | unknown | A | 0% |
| 1 Nov 2022 | $2.6B | $1.7B – $3.0B | $2.6B (+2%) | after a round | 370 | unknown | A | 0% |
| 1 Dec 2022 | $2.6B | $1.7B – $3.0B | $2.6B (0%) | after a round | 370 | unknown | A | 0% |
| 1 Jan 2023 | $2.6B | $1.6B – $3.0B | $2.6B (0%) | after a round | 370 | unknown | B | 0% |
| 1 Feb 2023 | $2.6B | $1.6B – $3.0B | $2.6B (0%) | after a round | 370 | unknown | B | 0% |
| 1 Mar 2023 | $2.6B | $1.5B – $3.0B | $2.6B (0%) | after a round | 370 | unknown | B | 0% |
| 1 Apr 2023 | $2.9B | $1.9B – $3.4B | $2.9B (0%) | after a round | 650 | growing | A | 0% |
| 1 May 2023 | $2.9B | $1.9B – $3.4B | $2.9B (0%) | after a round | 650 | growing | A | 0% |
| 1 Jun 2023 | $2.9B | $1.9B – $3.4B | $2.9B (0%) | after a round | 650 | growing | A | 0% |
| 1 Jul 2023 | $2.9B | $2.0B – $3.4B | $2.9B (0%) | after a round | 650 | growing | A | 0% |
| 1 Aug 2023 | $2.9B | $2.0B – $3.4B | $2.9B (0%) | after a round | 650 | growing | A | 0% |
| 1 Sep 2023 | $2.9B | $2.0B – $3.4B | $2.9B (0%) | after a round | 650 | growing | A | 0% |
| 1 Oct 2023 | $3.0B | $1.8B – $3.5B | $3.0B (0%) | after a round | 720 | up | B | 0% |
| 1 Nov 2023 | $3.0B | $1.8B – $3.5B | $3.0B (0%) | after a round | 720 | up | B | 0% |
| 1 Dec 2023 | $3.0B | $1.6B – $3.5B | $3.0B (0%) | after a round | 720 | up | B | 0% |
| 1 Jan 2024 | $3.0B | $1.6B – $3.5B | $3.0B (-1%) | after a round | 720 | up | B | 0% |
| 1 Feb 2024 | $3.0B | $1.5B – $3.5B | $3.0B (-1%) | after a round | 720 | up | B | 0% |
| 1 Mar 2024 | $3.1B | $1.5B – $3.5B | $3.0B (-1%) | after a round | 770 | up | B | 0% |
| 1 Apr 2024 | $3.1B | $1.5B – $3.5B | $3.0B (-2%) | after a round | 770 | up | B | 0% |
| 1 May 2024 | $3.1B | $1.5B – $3.5B | $3.0B (-2%) | after a round | 770 | up | B | 0% |
| 1 Jun 2024 | $3.1B | $1.5B – $3.5B | $3.0B (-2%) | after a round | 770 | up | B | 0% |
| 5 Jun 2024 | $3.0B | $2.6B – $3.8B | $3.3B (+10%) | after a round | 770 | up | A | 0% |
| 1 Jul 2024 | $3.0B | $2.6B – $3.8B | $3.3B (+9%) | after a round | 770 | up | A | 0% |
| 1 Aug 2024 | $3.0B | $2.6B – $3.8B | $3.3B (+8%) | after a round | 770 | up | A | 0% |
| 1 Sep 2024 | $3.1B | $2.6B – $3.8B | $3.3B (+7%) | after a round | 770 | up | A | 0% |
| 1 Oct 2024 | $3.1B | $2.6B – $3.8B | $3.3B (+7%) | after a round | 770 | up | A | 0% |
| 1 Nov 2024 | $3.1B | $2.6B – $3.8B | $3.3B (+6%) | after a round | 770 | flat | A | 0% |
| 1 Dec 2024 | $3.1B | $2.6B – $3.8B | $3.3B (+5%) | after a round | 770 | flat | A | 0% |
| 1 Jan 2025 | $3.2B | $2.6B – $3.8B | $3.3B (+4%) | after a round | 770 | flat | A | 0% |
| 1 Feb 2025 | $3.2B | $2.6B – $3.8B | $3.3B (+3%) | after a round | 770 | flat | A | 0% |
| 1 Mar 2025 | $3.2B | $2.6B – $3.8B | $3.3B (+3%) | after a round | 770 | flat | A | 0% |
| 1 Apr 2025 | $3.2B | $2.6B – $3.8B | $3.3B (+2%) | after a round | 770 | flat | A | 0% |
| 1 May 2025 | $3.3B | $2.6B – $3.8B | $3.3B (+1%) | after a round | 770 | unknown | A | 0% |
| 1 Jun 2025 | $3.3B | $2.6B – $3.8B | $3.3B (0%) | after a round | 770 | unknown | A | 0% |
| 18 Jun 2025 | $3.9B | $3.4B – $5.0B | $4.3B (+10%) | after a round | 770 | unknown | A | 0% |
| 1 Jul 2025 | $3.9B | $3.4B – $5.0B | $4.3B (+10%) | after a round | 987 | up | A | 0% |
| 1 Aug 2025 | $4.0B | $3.4B – $5.0B | $4.3B (+9%) | after a round | 1,009 | up | A | 0% |
| 1 Sep 2025 | $4.0B | $3.4B – $5.0B | $4.3B (+8%) | after a round | 1,009 | up | A | 0% |
| 1 Oct 2025 | $4.0B | $3.4B – $5.0B | $4.3B (+7%) | after a round | 1,009 | flat | A | 0% |
| 1 Nov 2025 | $4.0B | $3.4B – $4.7B | $3.8B (-4%) | after a round | 934 | flat | A | 49% |
| 1 Dec 2025 | $4.0B | $3.4B – $4.7B | $3.8B (-6%) | after a round | 934 | flat | A | 49% |
| 1 Jan 2026 | $4.0B | $3.4B – $4.7B | $3.7B (-8%) | after a round | 934 | flat | A | 49% |
| 1 Feb 2026 | $4.1B | $3.4B – $4.8B | $3.8B (-7%) | after a round | 1,128 | up | A | 45% |
| 1 Mar 2026 | $4.1B | $3.4B – $4.9B | $3.8B (-7%) | after a round | 1,128 | up | A | 42% |
| 1 Apr 2026 | $4.2B | $3.4B – $4.9B | $3.8B (-8%) | after a round | 1,128 | up | A | 38% |
| 1 May 2026 | $4.2B | $3.4B – $4.9B | $3.9B (-8%) | after a round | 1,180 | up | A | 35% |
| 1 Jun 2026 | $4.3B | $3.4B – $5.0B | $3.9B (-9%) | after a round | 1,180 | up | A | 32% |
| 1 Jul 2026 | $4.3B | $3.4B – $5.0B | $3.9B (-10%) | after a round | 1,180 | up | A | 30% |
| 1 Aug 2026 | $4.3B | $3.3B – $5.0B | $3.9B (-9%) | after a round | 1,180 | up | A | 27% |
| 1 Sep 2026 | $4.3B | $3.2B – $5.0B | $3.9B (-9%) | after a round | 1,180 | up | A | 25% |
| 1 Oct 2026 | $4.3B | $3.1B – $5.0B | $3.9B (-8%) | after a round | 1,180 | up | A | 23% |
| 24 Oct 2026 | $4.2B | $3.0B – $5.0B | $3.9B (-8%) | after a round | 1,180 | up | A | 23% |
Key facts about Sword Health
- Founded
- 2015
- Headquarters
- New York, United States
- Employees
- about 1,130 +14% in a year
- Total raised
- $456M
- Funding rounds
- 7
- Last round
- Growth Equity Jun 2025
Sword Health was founded in 2015 by André Eiras, Fernando Correia, Márcio Colunas and Virgílio Bento.
Sword Health funding history
Sword Health has 7 funding rounds on record, from Apr 2018 to Jun 2025, $456M in total. The latest disclosed valuation is $3.93B post-money (Growth Equity, Jun 2025).
Growth Equity 17 Jun 2025
Led by General Catalyst; with Khosla Ventures, Comcast Ventures, Lince Capital, Oxy Capital, Armilar Venture Partners, Indico Capital Partners, Shilling VC.
Sources: techstartups.com, mobihealthnews.com, cnbc.com and 1 more
$40M
$3.93B post-money
Growth Equity 4 Jun 2024
Led by Khosla Ventures.
Sources: techfundingnews.com, cooley.com, portugalglobal.pt and 1 more
$130M
$3.00B post-money
Series D 22 Nov 2021
Led by Sapphire Ventures; with Sozo Ventures, Willoughby Capital, ADQ, Localglobe, General Catalyst, Khosla Ventures, Founders Fund, BOND, Transformation Capital, Green Innovations.
Sources: swordhealth.com, goodwinlaw.com, globenewswire.com
$163M
$2.00B post-money
Series C 6 Jul 2021
Led by General Catalyst; with BOND, Highmark Ventures, BPEA Private Equity, Khosla Ventures, Founders Fund, Transformation Capital, Green Innovations.
Sources: finsmes.com, techcrunch.com, fiercehealthcare.com and 1 more
$85M
$500M post-money
Series B 1 Feb 2021
Led by Transformation Capital; with Khosla Ventures, Founders Fund, Green Innovations, Vesalius Biocapital, Faber.
Sources: globenewswire.com
$25M
$8.0M
Seed 16 Apr 2018
Led by Green Innovations, Vesalius Biocapital.
Sources: finsmes.com, techcrunch.com, mobihealthnews.com and 2 more
$4.6M
Sword Health investors
22 investors have backed Sword Health; Khosla Ventures, Green Innovations and General Catalyst and 3 more led at least one round.
- Khosla Ventures lead, 6 rounds
- General Catalyst lead, 3 rounds
- Sapphire Ventures lead
- Founders Fund 3 rounds
- BOND 2 rounds
- ADQ
- Comcast Ventures
- Highmark Ventures
- Localglobe
- Vesalius Biocapital
- Willoughby Capital
What Sword Health does
Sword Health works in health care services, with 12 recorded offerings and customers in healthcare.
Sword Health, Inc. is an American digital health company that develops and provides AI-driven healthcare solutions for musculoskeletal care, pelvic health, mental health, and movement health. The company offers digital physical therapy programs, pain prediction and prevention, and physical and mental health treatment, as well as a platform that integrates technology, accessory devices, and specialist support. Sword Health serves individuals, employers, health plans, unions, and consultants, and operates internationally with offices in the United States, Ireland, and Portugal. Its services are available in multiple languages.
Description from Veridion's company data.
Products and services
- AI-Driven Healthcare Solutions Development
- Pelvic Health Program Development
- Mental Health Program Development
- Movement Health Program Development
- Digital Physical Therapy Program Delivery
- Pain Prediction and Prevention Services
- AI-Powered Clinical Workflow Integration
- Healthcare Platform Integration Services
- Accessory Device Integration Services
- Clinical Specialist Network Services
- Multilingual Healthcare Services
- Diversity and Inclusion Healthcare Services
Markets
- Healthcare
Technology
- AI-Driven Personalized Care
- Machine Learning for Predictive Analytics
Business model
- Business-to-Business
- Business-to-Consumer
- Service Provider
- Healthcare
Industry codes (NAICS)
- 621399 Offices of All Other Miscellaneous Health Practitioners 70% match
- 541512 Computer Systems Design Services 30% match
Questions about Sword Health
What is Sword Health worth?
Valuation $4.2B (range $3.0B to $5.0B), as of 24 Oct 2026. The last disclosed valuation was $3.93B (Growth Equity, Jun 2025).
Has Sword Health raised money?
Sword Health has 7 funding rounds on record, from Apr 2018 to Jun 2025, $456M in total. The latest disclosed valuation is $3.93B post-money (Growth Equity, Jun 2025).
Who has invested in Sword Health?
Khosla Ventures, Green Innovations, General Catalyst, Transformation Capital, Sapphire Ventures and Vesalius Biocapital, and 16 more. Lead investors include Khosla Ventures, Green Innovations, General Catalyst and Transformation Capital.
How many people work at Sword Health?
About 1,130, up 14% over the last year. Headcount grew from 370 in Mar 2022 to 1,180 in May 2026.
What does Sword Health do?
Sword Health works in health care services, with 12 recorded offerings and customers in healthcare. Its main offerings are AI-Driven healthcare solutions development, pelvic health program development and mental health program development.
When was Sword Health founded, and where is it based?
Sword Health was founded in 2015 and is based in New York, United States. It has about 1,130 employees, up 14% over the last year.